Hyperthermia is an adjuvant treatment modality for cancer next to radiotherapy and chemotherapy. Hyperthermia is already in existance for decades but has lacked wide acceptance. ThinkThrough collaborates with major research institutes like AMC Amsterdam and Erasmus Medical Center Cancer Institute Daniël den Hoed to enable scientific studies on new hyperthermia solutions.
Earlier studies have proven to be major differentiators in patient outcome. Key element in the approach of ThinkThrough is international collaboration around technology solutions that combine quality of treatment, cost-effectiveness for the clinic and a high degree of usability for the practitioner.